Evidence map›Paper›PMID 40287486›Full record

ArticleScientific reports2025

A non-invasive diagnostic approach for neuroblastoma utilizing preoperative enhanced computed tomography and deep learning techniques.

Yuanyuan Wang, Fangfang Wang, Zixin Qin, Yongcheng Fu, Jingyue Wang, Shangkun Li, Da Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuanyuan WangDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, China.
Fangfang WangDepartment of Electronic information, Zhengzhou University Cyberspace Security College, Zhengzhou450000, Henan, China.
Zixin QinDepartment of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, Henan, China.
Yongcheng FuDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, China.
Jingyue WangDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, China.
Shangkun LiDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, China.
Da ZhangDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, China. zhd1000@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroblastoma presents a wide variety of clinical phenotypes, demonstrating different levels of benignity and malignancy among its subtypes. Early diagnosis is essential for effective patient management. Computed tomography (CT) serves as a significant diagnostic tool for neuroblastoma, utilizing machine vision imaging, which offers advantages over traditional X-ray and ultrasound imaging modalities. However, the high degree of similarity among neuroblastoma subtypes complicates the diagnostic process. In response to these challenges, this study presents a modified version of the You Only Look Once (YOLO) algorithm, called YOLOv8-IE. This revised approach integrates feature fusion and inverse residual attention mechanisms. The aim of YOLO-IE is to improve the detection and classification of neuroblastoma tumors. In light of the image features, we have implemented the inverse residual-based attention structure (iRMB) within the detection network of YOLOv8, thereby enhancing the model's ability to focus on significant features present in the images. Additionally, we have incorporated the centered feature pyramid EVC module. Experimental results show that the proposed detection network, named YOLO-IE, attains a mean Average Precision (mAP) 7.9% higher than the baseline model, YOLO. The individual contributions of iRMB and EVC to the performance improvement are 0.8% and 3.6% above the baseline model, respectively. This study represents a significant advancement in the field, as it not only facilitates the detection and classification of neuroblastoma but also demonstrates the considerable potential of machine learning and artificial intelligence in the realm of medical diagnosis.

Indexed as

Deep LearningNeuroblastomaTomography, X-Ray ComputedAlgorithmsHumansArtificial intelligenceDeep learningDiagnosisMachine learningNeuroblastoma

Identifiers

PMID40287486
PMCPMC12033241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.